Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 12:57 AM UTC
| NCT Number | NCT06297525 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 70 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Step Pharma, SAS |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of September 3, 2026: Clinical trial NCT06297525 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Step Pharma, SAS. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06297525 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297525 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.